Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas.

Schuster SJ, Huw LY, Bolen CR, Maximov V, Polson AG, Hatzi K, Lasater EA, Assouline SE, Bartlett NL, Budde LE, Matasar MJ, Koeppen H, Piccione EC, Wilson D, Wei MC, Yin S, Penuel E

Open source

DOI: 10.1182/blood.2023022348
Published: 2024 Feb 29
Container: Blood
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2023022348,
  title = {Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas.},
  author = {Schuster SJ and Huw LY and Bolen CR and Maximov V and Polson AG and Hatzi K and Lasater EA and Assouline SE and Bartlett NL and Budde LE and Matasar MJ and Koeppen H and Piccione EC and Wilson D and Wei MC and Yin S and Penuel E},
  year = {2024},
  journal = {Blood},
  doi = {10.1182/blood.2023022348},
  url = {https://doi.org/10.1182/blood.2023022348}
}

RIS

TY  - JOUR
TI  - Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas.
AU  - Schuster SJ
AU  - Huw LY
AU  - Bolen CR
AU  - Maximov V
AU  - Polson AG
AU  - Hatzi K
AU  - Lasater EA
AU  - Assouline SE
AU  - Bartlett NL
AU  - Budde LE
AU  - Matasar MJ
AU  - Koeppen H
AU  - Piccione EC
AU  - Wilson D
AU  - Wei MC
AU  - Yin S
AU  - Penuel E
PY  - 2024
JO  - Blood
DO  - 10.1182/blood.2023022348
UR  - https://doi.org/10.1182/blood.2023022348
ER  -

APA

SJ, S., LY, H., CR, B., V, M., AG, P., K, H., EA, L., SE, A., NL, B., LE, B., MJ, M., H, K., EC, P., D, W., MC, W., S, Y., & E, P. (2024). Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas.. Blood. https://doi.org/10.1182/blood.2023022348

Source records

pubmed · retrieved 2026-09-27T01:13:18.045Z